Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124972923 | 12497292 | 3 | F | 20160919 | 20160624 | 20160920 | EXP | US-BAYER-2016-047476 | BAYER | 72.00 | YR | E | F | Y | 112.00000 | KG | 20160920 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124972923 | 12497292 | 1 | PS | ADEMPAS | RIOCIGUAT | 1 | Oral | UNK | 204819 | ||||||||||
| 124972923 | 12497292 | 2 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2 MG, TID | BXH6TG1 | 204819 | 2 | MG | TID | ||||||
| 124972923 | 12497292 | 3 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2.5 MG, UNK | BXH8FC1 | 204819 | 2.5 | MG | |||||||
| 124972923 | 12497292 | 4 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2.5 MG, TID | BXH8FC2 | 204819 | 2.5 | MG | TID | ||||||
| 124972923 | 12497292 | 5 | SS | LETAIRIS | AMBRISENTAN | 1 | Unknown | 5 MG, QD | SBFP | 0 | 5 | MG | QD | ||||||
| 124972923 | 12497292 | 6 | C | OXYGEN. | OXYGEN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124972923 | 12497292 | 1 | Pulmonary arterial hypertension |
| 124972923 | 12497292 | 2 | Pulmonary arterial hypertension |
| 124972923 | 12497292 | 3 | Pulmonary arterial hypertension |
| 124972923 | 12497292 | 4 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124972923 | 12497292 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124972923 | 12497292 | Adverse event | |
| 124972923 | 12497292 | Dry mouth | |
| 124972923 | 12497292 | Dry skin | |
| 124972923 | 12497292 | Dyspnoea | |
| 124972923 | 12497292 | Joint swelling | |
| 124972923 | 12497292 | Oedema peripheral | |
| 124972923 | 12497292 | Pruritus | |
| 124972923 | 12497292 | Pulmonary thrombosis | |
| 124972923 | 12497292 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124972923 | 12497292 | 1 | 20151016 | 0 | ||
| 124972923 | 12497292 | 5 | 20150610 | 0 |